James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 1,141 shares at $53.04 ($61K) on 2019-06-06, disclosed to the SEC on 2019-06-10.
Scheduled sale ($61k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.04 | 200 | $11K | 17.3% |
| 2 | $53.06 | 370 | $20K | 31.9% |
| 3 | $54.65 | 100 | $5K | 8.9% |
| 4 | $54.65 | 271 | $15K | 24.1% |
| 5 | $54.70 | 200 | $11K | 17.8% |
| Total | $53.86 avg | 1,141 |
| $61K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-05-10 | $362K | — | Filing → |